SCHEMBL19988697

SCHEMBL19988697

c1ccc2c(c1)sc1c3[nH]c4cnccc4c3c3ccccc3c21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.51
GABRG2 P18507 2/20 0.51
GABRB3 P28472 2/20 0.51
GABRA5 P31644 2/20 0.51
GABRA3 P34903 2/20 0.51
GABRA2 P47869 2/20 0.51
CDK4 P11802 4/20 0.50
CCND1 P24385 4/20 0.50
MAP3K9 P80192 3/20 0.50
MAP3K11 Q16584 3/20 0.50
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
MAPT P10636 2/20 0.49
RAB9A P51151 2/20 0.49
NTRK1 P04629 1/20 0.48
MAP3K10 Q02779 1/20 0.48
TNKS O95271 1/20 0.48
TNKS2 Q9H2K2 1/20 0.48
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19988479 0.89 MEN1 (0.53) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL29848469 0.84 MEN1 (0.51) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL24767865 0.84 MEN1 (0.51) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL29506382 0.84 MEN1 (0.69) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL30887363 0.84 MEN1 (0.69) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL15138782 0.84 MEN1 (0.69) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL29865532 0.83 TNKS (0.71) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL23353331 0.83 TNKS (0.71) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL19988720 0.82 CHUK (0.63) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL19988477 0.81 GABRA1 (0.46) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512848-B1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-18 EP disclosed
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2019-07-11 US disclosed
WO-2018050583-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES CYCS, CYP3A4, CYP2E1 GABRA1 1058/4885GABRG2 1996/4885GABRB3 540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.